Abnormal Splicing in the Final Intron of PRX Results in Dominant Congenital Cataract Without Neurological Phenotype
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.14.28 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Linda M Reis and 9 co-authors. Institution: Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States. Major MEDLINE topics: Cataract, Introns, RNA Splicing, Membrane Proteins. 32 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Wellcome Trust, NIGMS NIH HHS, NEI NIH HHS.
Abstract (original language)
Purpose
Disrupted lens development can result in congenital cataract. Despite identifying over 50 genes linked to non-syndromic pediatric cataract, a causative mutation is found in only about 50% of affected families.
Methods
Exome and/or genome sequencing was undertaken in families with unexplained congenital cataract.
Results
Sequencing revealed heterozygous variants affecting splicing of the final intron of PRX in seven individuals from four families. PRX encodes periaxin, a protein necessary for the maintenance of peripheral nerve myelin and the proper organization of the lens cortex adherens junction. PRX has two major isoforms, differing in their final exon(s). For PRXb (L-PRX, 1461 amino acids), a small intron 6 separates exons 6 and 7; in PRXa (S-PRX, 147 amino acids), the intron is retained, generating a larger exon 6a but introducing an earlier stop codon. Loss-of-function variants affecting L-PRX (or both isoforms) cause recessive neurological phenotypes without cataract. The dominant cataract alleles identified here occur within the splice region of intron 6 and are predicted to cause abnormal splicing of PRXb (L-PRX). RNA sequencing confirmed aberrant splicing for all identified variants, including retention of intron 6, which ultimately results in a switch to the S-PRX isoform, and/or utilization of alternate donor or acceptor sites yielding small in-frame deletions in L-PRX.
Conclusions
Splicing defects leading to the replacement of L-PRX by S-PRX and/or the presence of an aberrant L-PRX exert a significant negative effect on lens development, possibly through a gain-of-function or dominant-negative mechanism distinct from the one implicated in recessive neurological phenotypes.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
- Institute of Ophthalmology, University College London, London, United Kingdom.
- Department of Ophthalmology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
- Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
- The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
- Postgraduate Program in Child and Adolescent, Department of Pediatrics, Federal University of Paraná, Curitiba, Brazil.
Funding
- Wellcome Trust
- NIGMS NIH HHS
- NEI NIH HHS
Cite
APA
Reis, L. M., Bellingham, J., Motta, F. L., Jurkute, N., Raskin, S., Ramos, F., Mahroo, O. A., Moosajee, M., Arno, G., & Semina, E. V. (2025). Abnormal Splicing in the Final Intron of PRX Results in Dominant Congenital Cataract Without Neurological Phenotype. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.14.28
Vancouver
Reis LM, Bellingham J, Motta FL, Jurkute N, Raskin S, Ramos F, et al. Abnormal Splicing in the Final Intron of PRX Results in Dominant Congenital Cataract Without Neurological Phenotype. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.14.28
BibTeX
@article{Reis2025,
author = {Reis, Linda M and Bellingham, James and Motta, Fabiana Louise and Jurkute, Neringa and Raskin, Salmo and Ramos, Fabiana and Mahroo, Omar A and Moosajee, Mariya and Arno, Gavin and Semina, Elena V},
title = {Abnormal Splicing in the Final Intron of PRX Results in Dominant Congenital Cataract Without Neurological Phenotype},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.14.28}
}
EUVIMED